scholarly journals Long‐term efficacy and safety of erenumab in migraine prevention: results from a 5‐year, open‐label treatment phase of a randomized clinical trial

2021 ◽  
Author(s):  
Messoud Ashina ◽  
Peter J Goadsby ◽  
Uwe Reuter ◽  
Stephen Silberstein ◽  
David W Dodick ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Treatment Phase ◽  
Migraine Prevention ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy

scholarly journals Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

2022 ◽  
Vol 239 ◽  
pp. 83-91
Author(s):  
Yuriy Filts ◽  
Robert E. Litman ◽  
Javier Martínez ◽  
Lourdes Anta ◽  
Dieter Naber ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

P150 LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

2020 ◽  
Vol 125 (5) ◽  
pp. S21
Author(s):  
A. Banerji ◽  
J. Hao ◽  
M. Yu ◽  
J. Bernstein ◽  
D. Johnston ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study

2016 ◽  
Vol 38 (9) ◽  
pp. 2058-2070.e1 ◽  
Author(s):  
Njira Lugogo ◽  
Christian Domingo ◽  
Pascal Chanez ◽  
Richard Leigh ◽  
Martyn J. Gilson ◽  
...  
Keyword(s):  
Efficacy And Safety ◽  
Open Label ◽  
Eosinophilic Asthma ◽  
Severe Eosinophilic Asthma ◽  
Term Efficacy ◽  
Phase Iiib ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document